Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Dasatinib × Clear all

NCT00439270 2014-03-28

Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer

Phase 1/2 Completed

49 enrolled 25 charts

Prostatic Neoplasms